Market Closed -
OTC Markets
13:57:52 2024-06-05 EDT
|
5-day change
|
1st Jan Change
|
0.002655
USD
|
+4.12%
|
|
+3.85%
|
+50.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
8.541
|
11.25
|
8.026
|
5.43
|
2.468
|
1.135
|
Enterprise Value (EV)
1 |
8.669
|
11.64
|
11.13
|
6.947
|
13.37
|
8.112
|
P/E ratio
|
-2.43
x
|
-0.78
x
|
-1.12
x
|
19.2
x
|
-0.55
x
|
-3.51
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
32,476
x
|
-
|
268
x
|
-
|
-
|
0.31
x
|
EV / Revenue
|
32,960
x
|
-
|
371
x
|
-
|
-
|
2.18
x
|
EV / EBITDA
|
-
|
-2,466,381
x
|
-8,708,550
x
|
-19,366,533
x
|
-29,531,755
x
|
21,325,862
x
|
EV / FCF
|
-8.63
x
|
-2.45
x
|
-3.4
x
|
-5.86
x
|
-7.47
x
|
-11.1
x
|
FCF Yield
|
-11.6%
|
-40.9%
|
-29.5%
|
-17.1%
|
-13.4%
|
-8.99%
|
Price to Book
|
2.8
x
|
1.14
x
|
-2.28
x
|
-2.52
x
|
-0.38
x
|
-0.16
x
|
Nbr of stocks (in thousands)
|
85,413
|
569,394
|
573,277
|
617,026
|
617,026
|
617,026
|
Reference price
2 |
0.1000
|
0.0198
|
0.0140
|
0.008800
|
0.004000
|
0.001840
|
Announcement Date
|
4/1/19
|
4/14/20
|
3/30/21
|
3/18/22
|
3/17/23
|
3/20/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.000263
|
-
|
0.03
|
-
|
-
|
3.72
|
EBITDA
|
-
|
-4.718
|
-1.279
|
-0.3587
|
-0.4528
|
0.3804
|
EBIT
1 |
-1.357
|
-4.829
|
-1.571
|
-1.33
|
-1.338
|
-0.4313
|
Operating Margin
|
-515,845.25%
|
-
|
-5,238.32%
|
-
|
-
|
-11.59%
|
Earnings before Tax (EBT)
1 |
-1.9
|
-10.37
|
-7.074
|
0.2729
|
-4.52
|
-0.3237
|
Net income
1 |
-1.9
|
-10.37
|
-7.074
|
0.2729
|
-4.52
|
-0.3237
|
Net margin
|
-722,563.12%
|
-
|
-23,579.57%
|
-
|
-
|
-8.7%
|
EPS
2 |
-0.0411
|
-0.0253
|
-0.0125
|
0.000458
|
-0.007325
|
-0.000524
|
Free Cash Flow
1 |
-1.004
|
-4.758
|
-3.279
|
-1.185
|
-1.79
|
-0.7296
|
FCF margin
|
-381,861.6%
|
-
|
-10,930.59%
|
-
|
-
|
-19.61%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/1/19
|
4/14/20
|
3/30/21
|
3/18/22
|
3/17/23
|
3/20/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.13
|
0.38
|
3.11
|
1.52
|
10.9
|
6.98
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-0.0815
x
|
-2.431
x
|
-4.23
x
|
-24.08
x
|
18.34
x
|
Free Cash Flow
1 |
-1
|
-4.76
|
-3.28
|
-1.18
|
-1.79
|
-0.73
|
ROE (net income / shareholders' equity)
|
-296%
|
-156%
|
-5,283%
|
-9.62%
|
104%
|
4.78%
|
ROA (Net income/ Total Assets)
|
-25%
|
-26%
|
-6.66%
|
-6.37%
|
-8.11%
|
-3.29%
|
Assets
1 |
7.598
|
39.93
|
106.2
|
-4.283
|
55.75
|
9.851
|
Book Value Per Share
2 |
0.0400
|
0.0200
|
-0.0100
|
-0
|
-0.0100
|
-0.0100
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
1 |
1.8
|
3.51
|
0.04
|
-
|
0
|
0.02
|
Capex / Sales
|
685,955.51%
|
-
|
141.68%
|
-
|
-
|
0.59%
|
Announcement Date
|
4/1/19
|
4/14/20
|
3/30/21
|
3/18/22
|
3/17/23
|
3/20/24
|
|
1st Jan change
|
Capi.
|
---|
| +50.00% | 1.64M | | +14.40% | 223M | | +2.06% | 211M | | +26.74% | 164M | | -28.57% | 120M | | +26.09% | 114M | | +96.16% | 110M | | -53.09% | 98.07M | | -3.85% | 86.5M | | +300.00% | 121M |
Medical Farming
|